| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Chief Legal Officer | Common Stock | 0 | $8.33 | Mar 6, 2023 | Direct | |
| CONCERT PHARMACEUTICALS, INC. | Chief Legal Officer | Stock Option (Right to Buy) | 0 | Mar 6, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CNCE | CONCERT PHARMACEUTICALS, INC. | Mar 6, 2023 | 5 | $0 | 4 | Mar 6, 2023 | Chief Legal Officer |
| CNCE | CONCERT PHARMACEUTICALS, INC. | Feb 15, 2023 | 1 | -$31.4K | 4 | Feb 16, 2023 | Chief Legal Officer |
| CNCE | CONCERT PHARMACEUTICALS, INC. | Jan 30, 2023 | 1 | -$70.9K | 4 | Jan 31, 2023 | Chief Legal Officer |
| CNCE | CONCERT PHARMACEUTICALS, INC. | Jan 6, 2023 | 1 | -$21K | 4 | Jan 9, 2023 | Chief Legal Officer |
| CNCE | CONCERT PHARMACEUTICALS, INC. | Feb 14, 2022 | 1 | -$11.6K | 4 | Feb 16, 2022 | Chief Legal Officer |
| CNCE | CONCERT PHARMACEUTICALS, INC. | Jan 28, 2022 | 1 | $0 | 4 | Feb 1, 2022 | Chief Legal Officer |
| CNCE | CONCERT PHARMACEUTICALS, INC. | Jan 5, 2022 | 1 | -$9.26K | 4 | Jan 7, 2022 | Chief Legal Officer |